CLINICAL_TRIALS
trial_result
· 2019-07-08
Clinical Trial Update: Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled [Phase 3]
Summary
Phase 3 clinical trial update for Busonid (budesonide 200 mcg and 400 mcg) in asthma shows the study is suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Asthma | Phase 3 | Status: SUSPENDED